/ Published in 2010, Publication

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, Baisley K, Tanton C, Hayes RJ, Marshak JO, Gladden RG, Koelle DM.
J Clin Microbiol. 2010 Oct;48(10):3496-503. Epub 2010 Aug 11.
PMID: 20702659
Related citation

What you can read next

Status of HPV vaccine introduction and barriers to country uptake.
Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilis.
Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.